Compound
D0513 | phenoxan
| Toxicity | Dose | Time | Species | Model | Method | Action | Positive criterion | Reference |
|---|---|---|---|---|---|---|---|---|
| ELECTRON TRANSPORT CHAIN | affect | 53 | ||||||
| ELECTRON TRANSPORT CHAIN | 0.04 nmol/mg | bovine | mitochondria | NADH–Q | decrease | IC50 | 94 | |
| Target | Dose | Time | Species | Model | Method | Action | Positive criterion | Reference |
|---|---|---|---|---|---|---|---|---|
| NADH:ubiquinone reductase | 0.04 nmol/mg | bovine | mitochondria | NADH–Q | inhibitor | IC50 | 94 | |
| semiquinone | antagonist | 53 | ||||||
| 134332-63-1 | 3-Ethyl-6-methoxy-5-methyl-2-(2-((3E)-3-methyl-4-phenyl-3-butenyl)-4-oxazolyl)-4H-pyran-4-one | 4H-Pyran-4-one, 3-ethyl-6-methoxy-5-methyl-2-(2-((3E)-3-methyl-4-phenyl-3-butenyl)-4-oxazolyl)- |
| 4H-Pyran-4-one, 3-ethyl-6-methoxy-5-methyl-2-(2-(3-methyl-4-phenyl-3-butenyl)-4-oxazolyl)-, (E)- | 4H-Pyran-4-one, 3-ethyl-6-methoxy-5-methyl-2-[2-[(3E)-3-methyl-4-phenyl-3-butenyl]-4-oxazolyl]- | 4H-Pyran-4-one,3-ethyl-6-methoxy-5-methyl-2-[2-[(3E)-3-methyl-4-phenyl-3-buten-1-yl]-4-oxazolyl]- |
| 5-ethyl-2-methoxy-3-methyl-6-[2-[(E)-3-methyl-4-phenyl-but-3-enyl]oxazol-4-yl]pyran-4-one; | CHEMBL2004336 | NSC 650914 |
| NSC-650914 | NSC650914 | Phenoxan |
| SCHEMBL19717663 | ZINC1632364 |
| CAS Number | 134332-63-1 |
| PubChem Compound | 5467345 |